Ind-Swift Laboratories Ltd.

Financial

	Ind-Swift Lab.	Kilitch Drugs(India)	Sakar Healthcare
Operational Metrics
Pharmaceutical Sector
Total reactor capacity	700.0 kL	n/a	n/a
DMF Filingsby API	474.0 .	n/a	n/a
R&D as a % of Total Sales	3.01 %	n/a	n/a
Financials
5 yr Average ROE	9.6 %	4.81 %	9.28 %
5yr average Equity Multiplier	2.49	1.42	1.75
5yr Average Asset Turnover Ratio	0.67	0.51	0.5
5yr Avg Net Profit Margin	6.7 %	6.07 %	10.38 %
Price to Book	0.77	3.85	2.67
P/E	3.23	29.13	38.61
5yr Avg Cash Conversion Cycle	76.78 Days	-7.56 Days	-14.29 Days
Inventory Days	126.74 Days	17.9 Days	46.75 Days
Days Receivable	95.44 Days	138.92 Days	51.16 Days
Days Payable	94.9 Days	199.26 Days	103.34 Days
5yr Average Interest Coverage Ratio	3.49	5.07	5.43
5yr Avg ROCE	12.63 %	8.16 %	10.08 %
5yr Avg Operating Profit Margin	19.31 %	9.07 %	24.06 %
5 yr average Debt to Equity	1.22	0.14	0.47
5yr CAGR Net Profit	n/a	77.02 %	3.94 %
5yr Average Return on Assets	7.66 %	3.38 %	5.37 %
Shareholdings
Promoter Holding	40.94 %	69.23 %	52.86 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-1.06 %	0.98 %	-14.68 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Ind-Swift Lab.	Kilitch Drugs(India)	Sakar Healthcare
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Loan Licensing 0 Export 0 CDMO 0	Product Wise Break-Up Export 0 Pharmaceutical 0 Loan Licensing 0 CDMO 0 Others 100	Product Wise Break-Up Export 73.0 Pharmaceutical 0 Loan Licensing 5.0 CDMO 22.0
Location Wise Break-Up	Location Wise Break-Up India 21.75 Rest of the World 0 International 0 Domestic 0 Others 78.25	Location Wise Break-Up Rest of the World 53.74 India 45.76 International 0 Domestic 0 Others 0.5	Location Wise Break-Up Rest of the World 0 India 0 International 61.9 Domestic 38.1
Operating Profit Break-Up	Operating Profit Break-Up India 18.87 Others 81.13	-	-
Asset Break-Up	Asset Break-Up India 67.55 Others 32.45	-	-